News

Currently, OncoMed is conducting a Phase Ib clinical trial of demcizumab in combination with Abraxane (nab-paclitaxel) and gemcitabine in first-line Stage IV pancreatic cancer patients. OncoMed chairman and

ORALAIR is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro

CRF trustee and president Nancy Stack noted that the foundation is on the brink of new possibilities and treatments. Stack spoke of CRF-funded stem cell and gene therapy

The study is aimed at evaluating numerous clinical factors and the microbiome in a select cohort of approximately 900 individuals with varying metabolic phenotypes to better understand the

Study site for this first enrollment is Malaysia. The Phase III study has been designed to evaluate the safety, efficacy and pharmacokinetics of its rVIII-SingleChain for the treatment

Ruthigen plans to begin its combined Phase I/II clinical trial for its lead drug candidate RUT58-60 as early as July 2014. The study may be conducted at up

The Phase 1 study has been designed to assess the safety, pharmacokinetics and pharmacodynamics of escalating doses of LOXO-101. In a second stage, it will also provide a

This patent, along with related patents issued in June 2013 (US Patent no. 8,461,157) and February 2013 (US Patent No. 8,367,663), covers a broad range of proprietary chemical

Financial terms of the agreement were not disclosed by the two companies. Pursuant to the terms of the agreement, Sofgen Pharmaceuticals will be responsible for development, manufacturing and